AAAAAA
Results: 1-25/26
Authors:
Dornfeld, KJ
Lawrence, TS
Citation: Kj. Dornfeld et Ts. Lawrence, A predisposition supposition for glioma, J NAT CANC, 93(20), 2001, pp. 1512-1513
Authors:
Ethier, SP
Lawrence, TS
Citation: Sp. Ethier et Ts. Lawrence, Epidermal growth factor receptor signaling and response of cancer cells toionizing radiation, J NAT CANC, 93(12), 2001, pp. 890-891
Authors:
Lawrence, TS
Davis, MA
Hough, A
Rehemtulla, A
Citation: Ts. Lawrence et al., The role of apoptosis in 2 ',2 '-difluoro-2 '-deoxycytidirne (gemcitabine)-mediated radiosensitization, CLIN CANC R, 7(2), 2001, pp. 314-319
Authors:
Ding, ZH
Parchment, RE
LoRusso, PM
Zhou, JY
Li, J
Lawrence, TS
Sun, Y
Wu, GS
Citation: Zh. Ding et al., The investigational new drug XK469 induces G(2)-M cell cycle arrest by p53-dependent and -independent pathways, CLIN CANC R, 7(11), 2001, pp. 3336-3342
Authors:
McGinn, CJ
Lawrence, TS
Citation: Cj. Mcginn et Ts. Lawrence, Recent advances in the use of radio sensitizing nucleosides, SEM RAD ONC, 11(4), 2001, pp. 270-280
Authors:
Dawson, LA
Ten Haken, RK
Lawrence, TS
Citation: La. Dawson et al., Partial irradiation of the liver, SEM RAD ONC, 11(3), 2001, pp. 240-246
Authors:
Eisbruch, A
Shewach, DS
Bradford, CR
Littles, JF
Teknos, TN
Chepeha, DB
Marentette, LJ
Terrell, JE
Hogikyan, ND
Dawson, LA
Urba, S
Wolf, GT
Lawrence, TS
Citation: A. Eisbruch et al., Radiation concurrent with gemcitabine for locally advanced head and neck cancer: A phase I trial and intracellular drug incorporation study, J CL ONCOL, 19(3), 2001, pp. 792-799
Authors:
McGinn, CJ
Zalupski, MM
Shureiqi, I
Robertson, JM
Eckhauser, FE
Smith, DC
Brown, D
Hejna, G
Strawderman, M
Normolle, D
Lawrence, TS
Citation: Cj. Mcginn et al., Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer, J CL ONCOL, 19(22), 2001, pp. 4202-4208
Authors:
Dawson, LA
Brock, KK
Kazanjian, S
Fitch, D
McGinn, CJ
Lawrence, TS
Ten Haken, RK
Balter, J
Citation: La. Dawson et al., The reproducibility of organ position using active breathing control (ABC)during liver radiotherapy, INT J RAD O, 51(5), 2001, pp. 1410-1421
Authors:
Symon, Z
Levi, M
Ensminger, WD
Smith, DE
Lawrence, TS
Citation: Z. Symon et al., Selective radioprotection of hepatocytes by systemic and portal vein infusions of amifostine in a rat liver tumor model, INT J RAD O, 50(2), 2001, pp. 473-478
Profiling of cancer cells using protein microarrays: Discovery of novel radiation-regulated proteins
Authors:
Sreekumar, A
Nyati, MK
Varambally, S
Barrette, TR
Ghosh, D
Lawrence, TS
Chinnaiyan, AM
Citation: A. Sreekumar et al., Profiling of cancer cells using protein microarrays: Discovery of novel radiation-regulated proteins, CANCER RES, 61(20), 2001, pp. 7585-7593
Authors:
Dawson, LA
McGinn, CJ
Normolle, D
Ten Haken, RK
Walker, S
Ensminger, W
Lawrence, TS
Citation: La. Dawson et al., Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies, J CL ONCOL, 18(11), 2000, pp. 2210-2218
Authors:
Fields, MT
Eisbruch, A
Normolle, D
Orfall, A
Davis, MA
Pu, AT
Lawrence, TS
Citation: Mt. Fields et al., Radiosensitization produced in vivo by once- vs. twice-weekly 2 ' 2 '-difluoro-2 '-deoxycytidine (gemcitabine), INT J RAD O, 47(3), 2000, pp. 785-791
Authors:
Chen, M
Hough, AM
Lawrence, TS
Citation: M. Chen et al., The role of p53 in gemcitabine-mediated cytotoxicity and radiosensitization, CANC CHEMOT, 45(5), 2000, pp. 369-374
Authors:
Aung, TT
Davis, MA
Ensminger, WD
Lawrence, TS
Citation: Tt. Aung et al., Interaction between gemcitabine and mitomycin-C in vitro, CANC CHEMOT, 45(1), 2000, pp. 38-42
Authors:
Lawrence, TS
Burke, R
Davis, MA
Wygoda, MR
Citation: Ts. Lawrence et al., Lack of effect of TP53 status on fluorodeoxyuridine-mediated radiosensitization, RADIAT RES, 154(2), 2000, pp. 140-144
Authors:
Kievit, E
Nyati, MK
Ng, E
Stegman, LD
Parsels, J
Ross, BD
Rehemtulla, A
Lawrence, TS
Citation: E. Kievit et al., Yeast cytosine deaminase improves radiosensitization and bystander effect by 5-fluorocytosine of human colorectal cancer xenografts, CANCER RES, 60(23), 2000, pp. 6649-6655
Authors:
Diep, DB
Nelson, KL
Lawrence, TS
Sellman, BR
Tweten, RK
Buckley, JT
Citation: Db. Diep et al., Expression and properties of an aerolysin - Clostridium septicum alpha toxin hybrid protein, MOL MICROB, 31(3), 1999, pp. 785-794
Authors:
Lawrence, TS
Eisbruch, A
McGinn, CJ
Fields, MT
Shewach, DS
Citation: Ts. Lawrence et al., Radiosensitization by gemcitabine, ONCOLOGY-NY, 13(10), 1999, pp. 55-60
Authors:
Eisbruch, A
Robertson, JM
Johnston, CM
Tworek, J
Reynolds, KR
Roberts, JA
Lawrence, TS
Citation: A. Eisbruch et al., Bromodeoxyuridine alternating with radiation for advanced uterine cervix cancer: A phase I and drug incorporation study, J CL ONCOL, 17(1), 1999, pp. 31-40
Authors:
Martel, MK
Ten Haken, RK
Hazuka, MB
Kessler, ML
Strawderman, M
Turrisi, AT
Lawrence, TS
Fraass, BA
Lichter, AS
Citation: Mk. Martel et al., Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients, LUNG CANC, 24(1), 1999, pp. 31-37
Authors:
Shureiqi, I
Wojno, KJ
Poore, JA
Reddy, RG
Moussalli, MJ
Spindler, SA
Greenson, JK
Normolle, D
Hasan, AAK
Lawrence, TS
Brenner, DE
Citation: I. Shureiqi et al., Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers, CARCINOGENE, 20(10), 1999, pp. 1985-1995
Authors:
Stegman, LD
Rehemtulla, A
Beattie, B
Kievit, E
Lawrence, TS
Blasberg, RG
Tjuvajev, JG
Ross, BD
Citation: Ld. Stegman et al., Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy, P NAS US, 96(17), 1999, pp. 9821-9826
Authors:
Kievit, E
Bershad, E
Ng, E
Sethna, P
Dev, I
Lawrence, TS
Rehemtulla, A
Citation: E. Kievit et al., Superiority of yeast over bacterial cytosine deaminase for emzyme/prodrug gene therapy in colon cancer xenografts, CANCER RES, 59(7), 1999, pp. 1417-1421
Authors:
Brodsky, RA
Mukhina, GL
Nelson, KL
Lawrence, TS
Jones, RJ
Buckley, JT
Citation: Ra. Brodsky et al., Resistance of paroxysmal nocturnal hemoglobinuria cells to the glycosylphosphatidylinositol-binding toxin aerolysin, BLOOD, 93(5), 1999, pp. 1749-1756